SAN DIEGO, CA, ClearNote Health, a company dedicated to improving early detection for some of the deadliest cancers, announced the close of $52 million in Series D financing, along with the appointment of industry veteran Kevin Keegan as president and chief operating officer. The financing and leadership expansion position ClearNote Health to accelerate growth amid increasing demand for more accurate, accessible, and affordable noninvasive tools for early cancer detection.

With this Series D financing, the company has received total funding of more than $185 million from leading institutional investors. The round was led by founding investor Mattias Westman and a global, large, long-only active manager. Other participants included former CEO and chairman of Citigroup Sandy Weill, ClearNote Health co-founder Dr. Stephen Quake of Stanford University, a large Seattle-based family office, and other U.S. and international-based institutional investors.